New Delhi On behalf of Pfizer Inc., there has been news of relief for the people suffering from Coronavirus. The company has declared its vaccine to be 90 percent effective for epidemic prevention. Meanwhile, Pfizer Inc. has announced that the first delivery of the vaccine will be in some states of the United States.
It is expensive to store the vaccine
The company says that ultra-cold storage is needed while transporting the vaccine from one place to another. In such a situation, it is a challenging task for the company to launch the first delivery of its vaccine. It is being told that keeping Pfizer vaccines in ultra-cold storage is quite expensive and sometimes logically difficult. Particularly distributing it to distant states is a difficult task. During the winter, Pfizer’s vaccine has to be kept at a temperature of -70 ° C in Antarctica. This vaccine can be stored for 5 days.
See also- DNA analysis: claim to make the most effective vaccine for coronavirus, know how effective this vaccine is
Vaccine will be distributed in these US states
The company has announced on Tuesday that it is going to start pilot programs soon. Pfizer said, “We hope our vaccine delivery program results will be a model for other US states and international governments.” For the vaccine pilot program, Pfizer Inc. has prominently selected the states of Rhode Island, New Mexico, Texas and Tennessee in the US, where the Kovid-19 vaccine will be distributed. The company has chosen them keeping in mind the diversity of these states, infrastructure for vaccination. The company says that these four states of America will not get vaccine supplements before other states and will not get preferential treatment.
Also read – India rebuked China for putting a check on changes in the United Nations, said this
By the third week of November, the company will also present the data of Kovid-19 patients who have recovered from their vaccine, when its last trial is successful. After this, the company will apply for the Emergency Use Authorization of the vaccine.
Pfizer vaccine is 90 percent effective
Significantly, last week, BioNotech and co-producer Pfizer said that Pfizer’s vaccine analysis showed that it could be effective in protecting Kovid-19 by more than 90 percent. On Friday, Israel also signed an agreement with the Pfizer Inc. company, under which 8 million doses of the COVID-19 vaccine will be received. Prime Minister Benjamin Netanyahu said, with this agreement, half of the population of Israel will get the Kovid-19 vaccine.